RESEARCH ARTICLES
Volume 8 |Issue 3| May-June 2020 First published: 30 June 2020
Sars COV-2: Complete review on Global pandemic (COVID-19)
Praveen Kumar Gupta, Rithu BS, Kauser Banu, Shruthi A and Sahana C
Department of Biotechnology, RV Collge Of Engineering, Bangalore, Karnataka, India
Abstract
Keywords:SARS COV 2,Life threatening, combat battle against virus.
Editor: Dr.Arvind Chavhan
Cite this article as:
Praveen Kumar Gupta, Rithu BS, Kauser Banu, Shruthi A and Sahana C. Sars COV-2: Complete review on Global pandemic (COVID-19), Int. Res. Journal of Science & Engineering, 2020, Volume 8(3): 101-108.
Copyright:
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/
References
1. www.niaid.nih.gov/diseases-conditions/coronaviruses
2. Tang JW et al. Emergence of a novel coron virus causing respiratory illness from Wuhan, China. Journal of Infection, 2020; 80: 350–371, doi: https://doi.org/10.1016/j.jinf.2020.01.014
3. Chatterjee P, et al. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. Indian J Med Res, Epub ahead of print. 2020, doi: 10.4103/ijmr.IJMR_519_20
4. Gorbalenya AE, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses - A statement of the Coronavirus Study Group. bioRxiv 2020. doi: https://doi. org/10.1101/2020.02.07.937862.
5. Kagne SR. New Coronavirus: Death warrant in China, Int. Res. Journal of Science & Engineering, 2020, Volume 8 Issue 1: 1-4
6. Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses 2010; 2:1804-20. doi: 10.3390/v2081803
7. Gennaro FD, et al. (2020). Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review. Int. J. Environ. Res. Public Health 2020, 17, 2690; doi:10.3390/ijerph17082690
8. Wang LS, et al. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence, International Journal of Antimicrobial Agents (2020), doi: https://doi.org/10.1016/j.ijantimicag.2020.105948
9. Sahin AR, et al. Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO 2020;4(1):1–7. doi: 10.14744/ejmo.2020.12220
10. Ahmed SS. The Coronavirus Disease 2019 (COVID-19): A Review. JAMMR, 2020, 32(4): 1-9, 2020; doi: 10.9734/JAMMR/2020/v32i430393
11. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
12. Jamwal A, Bhatnagar S, Sharma P. Coronavirus Disease 2019 (COVID-19): Current Literature and Status in India. Preprints 2020, 2020040189. doi: 10.20944/preprints202004. 0189.v1).
13. Sohrabi C et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg., 2020 Apr; 76:71-76. doi: 10.1016/j.ijsu.2020.02.034.
14. https://covid19.who.int/
15. https://www.covid19india.org/
16. Han Y et al. Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights into the Evolution and Origin of Coronavirus-Related Diseases. Front. Microbiol. 2019 10:1900. doi: 10.3389/fmicb.2019.01900
17. Lai CC, Shih TP and Ko WC et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents 2020, 55 105924. doi: https://doi.org/10.1016/j.ijantimicag.2020.105924
18. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html#emergence
19. https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
20. Van Doremalen N, Bushmaker T, Morris DH, Holbrook, MG, Gamble A, Williamson BN and Lloyd-Smith JO. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1”, New England Journal of Medicine, 2020.
21. Mark DeBeliso, Joseph M. Berning, Carole Carson, Trish Sevene, Chad Harris, Kent J. Adams, Joe Walsh, Mike Climstein,”COVID-19: Beyond Washing Your Hands and Social Distancing”, International Journal of Science and Engineering Investigations, 2020, vol. 9, issue 99, ISSN: 2251-8843, April 2020 Received on April 4 2020.
22. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2
23. van S, Boheemen M de Graaf, C Lauber Bestebroer TM, Raj VS, Zaki AM et al. “Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans”, MBio, 3 (6), pp. e00473-e512, (2012).
24. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC”, Nature, 495 (7440), pp. 251-254, (2013).
25. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis, Nat Rev Microbiol, 2009, 7 (6): 439-450.
26. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4, Cell Res, 2013, 23 (8): 986.
27. Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response”, J Virol., 2011, 85 (9) pp. 4122-4134.
28. Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease”, J Virol., 2011, 85 (24), pp. 13363-13372.
29. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China”, Nature, 2020, 1–5.
30. Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin”, Nature [Internet]., p. 3, Feb (2020).
31. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X et al. Evolution of the novel corona virus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission”, Science China Life Sciences, 2020, 63 (3), pp. 457-460.
32. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel corona virus from Wuhan: an analysis based on decade-long structural studies of SARS”, J Virol. 2020.
33. Muhammad Adnan Shereen, Suliman Khan, Naidia Bashir, Rabeea Siddique, “COVID-19 infection: Origin, transmission, and characteristics of human corona viruses”, Journal of Advanced Research, 2020,Volume 24, Pages 91-98, July 2020.
34. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). In StatPearls [Internet]. StatPearls Publishing, 2020.
35. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY et al. Diagnosing COVID-19: The Disease and Tools for Detection. ACS nano., 2020.
36. Singhal T. A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics, 2020, 1-6.
37. Chloe Kent. Different paths to the same destination: screening for Covid-19. Verdict medical devices, 2020.
38. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507–13.
39. Pastick KA, Okafor EC, Wang F, Lofgren SM, Skipper CP, Nicol MR, et al. Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). In Open Forum Infectious Diseases, 2020.
40. Singh AK, Singh A, Shaikh A, Singh R and Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020.
41. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A and Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of critical care, 2020.
42. Rithu BS. SARS COV 2 Identity matrix, Int. Res. Journal of Science & Engineering, 2020. Volume 8 (2) : 41-57.
